ABT On Other Exchanges
Symbol
Exchange
New York
Mexico
SIX Swiss Ex
London
Sao Paulo
text size: T | T
Back to Snapshot
Company Description

Contact Info

100 Abbott Park Road

Abbott Park, IL 60064

United States

Phone: 224-667-6100

Fax:

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a line of health care products. The company markets products worldwide through affiliates and distributors. Segments The company operates in four segments, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Established Pharmaceutical Products This segment’s products include a line of branded generic pharmaceuticals manufactured worldwide, and marketed and sold outside the United States. These products are generally sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from the company-owned distribution centers and public warehouses, depending on the market served. Certain products are co-marketed or co-promoted with, or licensed from, other companies. The principal products included in the therapeutic area portfolios of the Established Pharmaceutical Products segment are: Gastroenterology products, including Creon, for the treatment of pancreatic exocrine insufficiency associated with various underlying conditions, including cystic fibrosis and chronic pancreatitis; Duspatal and Dicetel, for the treatment of irritable bowel syndrome or biliary spasm; Heptral, Transmetil, Samyr, and Donamet, for the treatment of intrahepatic cholestasis (associated with liver disease) or depressive symptoms; and Duphalac, for regulation of the physiological rhythm of the colon. Women's health products, including Duphaston, for the treatment of different gynecological disorders; and Femoston, a hormone replacement therapy for postmenopausal women. Cardiovascular and metabolic products, including Lipanthyl and TriCor, for the treatment of dyslipidemia; Teveten and Teveten Plus, for the treatment of essential hypertension, and Physiotens, for the treatment of hypertension; and Synthroid, for the treatment of hypothyroidism. Pain and central nervous system products, including Serc, for the treatment of Ménière's disease and vestibular vertigo; Brufen, for the treatment of pain, fever, and inflammation; and Sevedol, for the treatment of severe migraines. Respiratory drugs and vaccines, including the anti-infective clarithromycin (sold under the trademarks, Biaxin, Klacid, and Klaricid); and Influvac, an influenza vaccine. This segment directs its primary marketing efforts toward building a brand with key stakeholders, including consumers, pharmacists, physicians, and other healthcare providers. Government agencies are also important customers. Diagnostic Products This segment’s products include a line of diagnostic systems and tests manufactured, marketed, and sold worldwide. These products are generally marketed and sold directly to blood banks, hospitals, commercial laboratories, clinics, physicians' offices, government agencies, alternate care testing sites, and plasma protein therapeutic companies from the company-owned distribution centers, public warehouses or third party distributors. The principal products included in the Diagnostic Products segment are: Immunoassay and clinical chemistry systems, including ARCHITECT and ABBOTT PRISM, with assays used for screening and/or diagnosis for cancer, cardiac, drugs of abuse, fertility, general chemistries, infectious diseases (such as hepatitis and HIV), and therapeutic drug monitoring. A line of hematology systems and reagents known as the Cell-Dyn series. The i-STAT point-of-care diagnostic systems and cartridges for blood analysis. m2000, an instrument that automates the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents including HIV, HBV, HCV, HPV, and CT/NG. The Vysis FISH product line of genomic-based tests, including the PathVysion HER-2 DNA probe kit; the UroVysion bladder cancer recurrence kit; and the Vysis ALK Break Apart FISH Probe Kit, the U.S. Food and Drug Administration-approved companion diagnostic to Pfizer's approved non-small-cell lung cancer therapy XALKORI. Informatics and automation solutions for use in laboratories, including ACCELERA

 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

ABT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ABT.
View Industry Companies
 

Industry Analysis

ABT

Industry Average

Valuation ABT Industry Range
Price/Earnings 33.1x
Price/Sales 3.1x
Price/Book 3.1x
Price/Cash Flow 22.1x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ABBOTT LABORATORIES, please visit www.abbott.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.